Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A subset of presympathetic-premotor neurons within the centrally projecting Edinger-Westphal nucleus expresses urocortin-1.

Shah NS, Pugh PC, Nam H, Rosenthal DT, van Wijk D, Gaszner B, Kozicz T, Kerman IA.

J Chem Neuroanat. 2013 Sep;52:25-35. doi: 10.1016/j.jchemneu.2013.04.004. Epub 2013 May 22.

2.

RhoC impacts the metastatic potential and abundance of breast cancer stem cells.

Rosenthal DT, Zhang J, Bao L, Zhu L, Wu Z, Toy K, Kleer CG, Merajver SD.

PLoS One. 2012;7(7):e40979. doi: 10.1371/journal.pone.0040979. Epub 2012 Jul 23.

3.

Rethinking the war on cancer: multidisciplinary collaborations between biologists and physical scientists.

Rosenthal DT, Merajver SD.

Future Oncol. 2012 Apr;8(4):339-41. doi: 10.2217/fon.12.13. No abstract available.

4.

High novelty-seeking predicts aggression and gene expression differences within defined serotonergic cell groups.

Kerman IA, Clinton SM, Bedrosian TA, Abraham AD, Rosenthal DT, Akil H, Watson SJ.

Brain Res. 2011 Oct 24;1419:34-45. doi: 10.1016/j.brainres.2011.08.038. Epub 2011 Aug 22.

5.

p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior.

Rosenthal DT, Iyer H, Escudero S, Bao L, Wu Z, Ventura AC, Kleer CG, Arruda EM, Garikipati K, Merajver SD.

Cancer Res. 2011 Oct 15;71(20):6338-49. doi: 10.1158/0008-5472.CAN-11-1291. Epub 2011 Aug 23.

6.

From in vitro to in silico and back again: using biological and mathematical synergy to decipher breast cancer cell motility.

Rosenthal DT, Iyer H, Escudero S, Ventura AC, Arruda EM, Garikipati K, Merajver SD.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:3261-4. doi: 10.1109/IEMBS.2010.5627224.

PMID:
21096609
7.

Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.

Wu M, Wu ZF, Rosenthal DT, Rhee EM, Merajver SD.

Cancer. 2010 Jun 1;116(11 Suppl):2768-82. doi: 10.1002/cncr.25181.

8.

Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland.

Pan Q, Rosenthal DT, Bao L, Kleer CG, Merajver SD.

Clin Cancer Res. 2009 Dec 1;15(23):7441-6. doi: 10.1158/1078-0432.CCR-09-1361. Epub 2009 Nov 24.

9.

Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.

Dissanayake SK, Olkhanud PB, O'Connell MP, Carter A, French AD, Camilli TC, Emeche CD, Hewitt KJ, Rosenthal DT, Leotlela PD, Wade MS, Yang SW, Brant L, Nickoloff BJ, Messina JL, Biragyn A, Hoek KS, Taub DD, Longo DL, Sondak VK, Hewitt SM, Weeraratna AT.

Cancer Res. 2008 Dec 15;68(24):10205-14. doi: 10.1158/0008-5472.CAN-08-2149.

10.

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.

Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, Bittner M, Weeraratna AT.

J Biol Chem. 2007 Jun 8;282(23):17259-71. Epub 2007 Apr 10.

11.

Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.

Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ, Taub DD, Kallioniemi OP, Meltzer P, Morin PJ, Weeraratna AT.

Oncogene. 2007 May 31;26(26):3846-56. Epub 2006 Dec 11.

PMID:
17160014
12.

QuickSilver clinical tracker - a risk-management approach.

Rosenthal DT, Chueh H.

AMIA Annu Symp Proc. 2003:989.

Supplemental Content

Loading ...
Support Center